Company / PP&E (Net)
CVS Health PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$13.1B
FY2025
5-year range
$12.9B / $13.2B
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#2 of 138
Health Care
What the data says
Among 138 Health Care companies, CVS Health is in the top 1% for pp&e (net). PP&E (Net) has fluctuated over the past 9 years, ranging from $10.2B in FY2016 to $13.2B in FY2023.
Based on SEC 10-K filings.
$13.1B in FY2025 with a 5-year CAGR of +0.7%. Ranks 2nd among 138 companies in Health Care.
Remained stable around $13.1B over the past 3 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- +0.7%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 138This company $13.1B Sector average $1.4B
▼
+826.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.7%, indicating consistent growth.
- Ranks #2 out of 138 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.1B | - |
| FY2024 | - | - |
| FY2023 | $13.2B | +2.4% |
| FY2022 | $12.9B | -0.2% |
| FY2021 | $12.9B | +2.3% |
| FY2020 | $12.6B | +4.7% |
| FY2019 | $12.0B | +6.1% |
| FY2018 | $11.3B | +10.3% |
| FY2017 | $10.3B | +1.1% |
| FY2016 | $10.2B | +3.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026